Shou Fang Wu
Kaohsiung Medical University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shou Fang Wu.
Bioorganic & Medicinal Chemistry Letters | 2012
Chi Ting Hsieh; Tusty Jiuan Hsieh; Mohamed El-Shazly; Da Wei Chuang; Yi Hong Tsai; Chiao Ting Yen; Shou Fang Wu; Yang Chang Wu; Fang Rong Chang
Chalcones bearing electron donating or electron withdrawing substitutions were prepared and their glucose uptake activity was evaluated. Chalcone derivatives were synthesized in one step protocol with high purity and yield. Chalcones with chloro, bromo, iodo and hydroxy substitutions at position 2 on A-ring exhibited the highest activity with glucose medium concentration (210 to 236 mg/dl) compared to pioglitazone and rosiglitazone (230 and 263 mg/dl, respectively). Also chalcones with iodo substitution at position 3 on A-ring were comparably active (≤238 mg/dl). The structure-activity relationship of the tested chalcones was studied and the findings were supported statistically.
Journal of Natural Products | 2011
Shou Fang Wu; Fang Rong Chang; Sheng-Yang Wang; Tsong Long Hwang; Chia Lin Lee; Shu Li Chen; Chin Chung Wu; Yang Chang Wu
Five new benzofurans, pterolinuses A-E (1-5), six new neoflavonoids, pterolinuses F-J (8-13), and five known compounds (6, 7, 14-16) were isolated from an extract of Pterocarpus santalinus heartwood. All new structures were elucidated by spectroscopic methods, and configurations were confirmed by CD spectral data and optical rotation values. The isolates were evaluated for anti-inflammatory and cytotoxic activities. Six compounds (1, 2, 4, 6, 7, and 15) showed significant inhibition in at least one anti-inflammatory assay. Compound 2 showed the best selective effect against superoxide anion generation in human neutrophils with, an IC50 value of 0.19 μg/mL, and was 6.2-fold more potent than the positive control LY294002. Compound 14 showed the highest cytotoxicity against Ca9-22 cancer cells, with an IC50 value of 0.46 μg/mL.
Food Chemistry | 2013
Yu Chi Tsai; Shang Yu Chiang; Mohamed El-Shazly; Chin Chung Wu; Ludger Beerhues; Wan Chun Lai; Shou Fang Wu; Ming Hong Yen; Yang Chang Wu; Fang Rong Chang
The ethanolic extract of Liriope platyphylla (Liliaceae) roots showed potential oestrogenic and anti-platelet activities. Twenty-six compounds were isolated and classified as 10 skeletons, including two unusual new dihydrobenzofuroisocoumarins, (+)-platyphyllarin A (1) and B (2), one new butanoate, ethyltributanoate (3), and two new homoisoflavanones, (-)-liriopein A (4) and B (5), along with 21 known compounds, including six homoisoflavonoids, one chalcone, six amides, one lignan, one fatty acid derivative, one alkaloid, three benzenoids, and two steroids. The biosynthetic pathway of compounds 1 and 2 was proposed in the current investigation. The oestrogenic activity of the isolates was evaluated utilising the pER8:GUS reporter assay system in transgenic Arabidopsis plant as well as the SEAP reporter assay system in MCF-7 breast cancer cell-line; the anti-platelet activity was evaluated using the anti-platelet aggregation assay. Several components exhibited significant oestrogenic and anti-platelet activities; demonstrating for the first time the potential use of L. platyphylla as a nutritional supplement for cardiovascular and endocrine diseases.
Journal of Viral Hepatitis | 2012
Shou Fang Wu; C. K. Lin; Y. S. Chuang; Fang Rong Chang; Chih-Hua Tseng; Yang Chang Wu; Jin Ching Lee
Summary. Chronic hepatitis C virus (HCV) infection ultimately leads to chronic hepatitis, hepatic cirrhosis and hepatocellular carcinoma (HCC). As the standard treatment is not completely efficacious, a safer and more effective agent against HCV infection needs to be developed. In this report, we demonstrated that 3‐hydroxy caruilignan C (3‐HCL‐C) isolated from Swietenia macrophylla stems exhibited high anti‐HCV activity at both protein and RNA levels at nontoxic concentrations, with an EC50 value of 10.5 ± 1.2 μm. Combinations of 3‐HCL‐C and interferon‐α (IFN‐α), an HCV NS5B polymerase inhibitor (2′‐C‐methylcytidine; NM‐107) or an HCV NS3/4A protease inhibitor (Telaprevir; VX‐950) increased the suppression of HCV RNA replication. The results suggested that 3‐HCL‐C may be a potential anti‐viral agent. We then demonstrated that 3‐HCL‐C interfered with HCV replication by inducing IFN‐stimulated response element transcription and IFN‐dependent anti‐viral gene expression.
Journal of Viral Hepatitis | 2011
Jin-Ching Lee; Chih-Hua Tseng; Shou Fang Wu; Fang Rong Chang; Chien-Chih Chiu; Yang Chang Wu
Summary. Chronic hepatitis C virus (HCV) infection is associated with chronic inflammation of liver, which leads to the development of cirrhosis and hepatocellular carcinoma (HCC). Because of severe side effects and only a 50–70% cure rate in genotype 1 HCV‐infected patients upon current standard treatment with pegylated interferon‐α plus ribavirin, new therapeutic regimens are still needed. San‐Huang‐Xie‐Xin‐Tang (SHXT) is a transitional Chinese herbal formula, composed of Rhei rhizoma, Scutellaria radix and Coptidis rhizome, and possesses anti‐inflammatory effect. Here, we describe a (+)‐catechin‐containing fraction extracted from SHXT, referred as SHXT‐frC, exhibited effective inhibition of HCV replication, with selectivity index value (SI; CC50/EC50) of 84, and displayed synergistic anti‐HCV effects when combined with interferon‐α, HCV protease inhibitor telaprevir or polymerase inhibitor 2′‐C‐methylcytidine. The activation of factor‐κB (NF‐κB) and cyclooxygenase‐2 (COX‐2) signalling pathway has particular relevance to HCV‐associated HCC. SHXT‐frC treatment also caused a concentration‐dependent decrease in the induction of COX‐2 and NF‐κB expression caused by either HCV replication or HCV NS5A protein. Collectively, SHXT‐frC could be an adjuvant treatment for patients with HCV‐induced liver diseases.
Bioorganic & Medicinal Chemistry Letters | 2011
Yu Ming Chung; Fang Rong Chang; Tseng Fu Tseng; Tsong Long Hwang; Lei Chin Chen; Shou Fang Wu; Chia Lin Lee; Zu Yau Lin; Li Yeh Chuang; Jinu Huang Su; Yang Chang Wu
A novel alkaloid, aristopyridinone A (1) and a new phenanthrene, aristolamide II (2), were isolated from Aristolochia manshuriensis (Guanmutong) together with eight known phenanthrenes (3-10). All structures were elucidated by spectroscopic methods. Compound 2 showed a selective inhibitory effect on elastase release by human neutrophils in response to fMLP with an IC(50) value of 4.11 μg/mL. Compound 7 exhibited significant inhibitory effects on superoxide anion generation and elastase release with IC(50) values of 0.12 and 0.20 μg/mL, respectively.
Bioorganic & Medicinal Chemistry Letters | 2011
Shou Fang Wu; Tsong Long Hwang; Shu Li Chen; Chin Chung Wu; Emika Ohkoshi; Kuo Hsiung Lee; Fang Rong Chang; Yang Chang Wu
One new phenanthrenedione, pterolinus K (1), and one new chalcone, pterolinus L (2) were isolated from the heartwood extract of Pterocarpus santalinus. The structures were elucidated by spectroscopic methods. Both 1 and 2 showed inhibitory effect on elastase release by human neutrophils in response to fMLP with an IC(50) value of 4.24 and 0.95 μM, and compound 1 also inhibited superoxide anion generation with IC(50) value of 0.99 μM. In addition, compound 1 showed selective cytotoxicity against HepG2 with IC(50) value of 10.86 μM, while compound 2 showed a moderate cytotoxicity against KB with IC(50) values of 17.18 μM.
Journal of Natural Products | 2012
Yu Chi Tsai; Wan Chun Lai; Ying Chi Du; Shou Fang Wu; Mohamed El-Shazly; Chia Lin Lee; Ming Hong Yen; Ming Feng Hou; Yang Chang Wu; Fang Rong Chang
In a search for natural phytoestrogens, 130 traditional Chinese medicinal extracts related to gynecological disorders were investigated by the Arabidopsis pER8:GUS reporter assay system. The EtOH extract of Cuscuta chinensis showed estrogenic activity (100 μg/mL) and affored three new lignans, cuscutaresinols A−C (1−3), and 16 known compounds. Cuscutaresinols A−C (1−3), (+)-sesamin (4), (+)-xanthoxylol (5), 9-hydroxysesamin (6), (+)-pinoresinol (7), kaempferol (8), and isorhamnetin (9) showed estrogenic activity, with 8 and 9 exhibiting the most potent activity. Kaempferol (8) and isorhamnetin (9) are the major components of C. chinenesis EtOH extract and the key contributors to its estrogenic activity in the Arabidopsis pER8:GUS reporter assay system. P are natural secondary metabolites that exhibit several positive effects on human health, such as improving menopausal syndrome, resisting oxidative damage accompanying neurological and cardiovascular diseases, and inhibiting tumor growth. Currently, phytoestrogens are one of the most important nutritional supplements. Phytoestrogens either are absorbed directly from the gastrointestinal tract or undergo metabolic conversion to the active form by gut microflora before absorption. Despite the wealth of evidence showing the biological importance of dietary phytoestrogens, their use for postmenopausal syndrome is still a controversial issue. Thus, finding new sources of phytoestrogens and developing feasible protocols for their detection in natural products will promote our understanding of their actual role. In 2005, we introduced a cross-kingdom bioassay to test animal biological functions utilizing a higher plant bioassay model. In this system, the transgenic Arabidopsis thaliana plant with the pER8:GUS reporter, bearing a human estrogenic receptor, is used as a tool for screening phytoestrogens from natural sources. The system was utilized for screening different plant extracts used to treat postmenopausal syndrome in traditional Chinese or folk medicine. Among the tested extracts, an EtOH extract of Cuscuta chinensis Lam. Received: December 16, 2011 Article
Frontiers in Pharmacology | 2017
Michal Korinek; Yi Hong Tsai; Mohamed El-Shazly; Kuei Hung Lai; Anders Backlund; Shou Fang Wu; Wan Chun Lai; Tung Ying Wu; Shu Li Chen; Yang Chang Wu; Yuan Bin Cheng; Tsong Long Hwang; Bing-Hung Chen; Fang Rong Chang
Increasing prevalence of allergic diseases with an inadequate variety of treatment drives forward search for new alternative drugs. Fatty acids, abundant in nature, are regarded as important bioactive compounds and powerful nutrients playing an important role in lipid homeostasis and inflammation. Phytochemical study on Typhonium blumei Nicolson and Sivadasan (Araceae), a folk anti-cancer and anti-inflammatory medicine, yielded four oxygenated fatty acids, 12R-hydroxyoctadec-9Z,13E-dienoic acid methyl ester (1) and 10R-hydroxyoctadec-8E,12Z-dienoic acid methyl ester (2), 9R-hydroxy-10E-octadecenoic acid methyl ester (3), and 12R*-hydroxy-10E-octadecenoic acid methyl ester (4). Isolated compounds were identified by spectroscopic methods along with GC-MS analysis. Isolated fatty acids together with a series of saturated, unsaturated and oxygenated fatty acids were evaluated for their anti-inflammatory and anti-allergic activities in vitro. Unsaturated (including docosahexaenoic and eicosapentaenoic acids) as well as hydroxylated unsaturated fatty acids exerted strong anti-inflammatory activity in superoxide anion generation (IC50 2.14–3.73 μM) and elastase release (IC50 1.26–4.57 μM) assays. On the other hand, in the anti-allergic assays, the unsaturated fatty acids were inactive, while hydroxylated fatty acids showed promising inhibitory activity in A23187- and antigen-induced degranulation assays (e.g., 9S-hydroxy-10E,12Z-octadecadienoic acid, IC50 92.4 and 49.7 μM, respectively). According to our results, the presence of a hydroxy group in the long chain did not influence the potent anti-inflammatory activity of free unsaturated acids. Nevertheless, hydroxylation of fatty acids (or their methyl esters) seems to be a key factor for the anti-allergic activity observed in the current study. Moreover, ChemGPS-NP was explored to predict the structure-activity relationship of fatty acids. The anti-allergic fatty acids formed different cluster distant from clinically used drugs. The bioactivity of T. blumei, which is historically utilized in folk medicine, might be related to the content of fatty acids and their metabolites.
Antiviral Research | 2011
Jin Ching Lee; Wei Chun Chen; Shou Fang Wu; Chin kai Tseng; Ching Yi Chiou; Fang Rong Chang; Shih hsien Hsu; Yang Chang Wu